Gleiberman Family Expands Legacy in Vision Research with $1 Million Gift and Endowed Chair Milestone
Hanna and Mark Gleiberman’s philanthropic support of vision care and research is strengthening the fight against blinding diseases, like glaucoma.
Hanna and Mark Gleiberman’s philanthropic support of vision care and research is strengthening the fight against blinding diseases, like glaucoma.
Researchers from UC San Diego School of Medicine found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, despite modest increases over the past decade.
UC San Diego and colleagues across the nation have announced the first data release from the HEALthy Brain and Child Development (HBCD) Study, offering a detailed look at early human brain development.
Dr. Royan Kamyar, MBA ’10, helps people harness the power of their circadian rhythms through his app, Owaves: BodyClock AI.
Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale University researchers highlights an innovative approach that may be safer: small nuclear RNA editing.
Gulf War illness, a chronic, debilitating condition linked to military service in the 1990-1991 Gulf War, will receive a dedicated diagnostic code in the October 2025 release of the International Classification of Diseases (ICD-10-CM).
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.